Pancreatic Cancer Research

ResearcherTongji UniversityActive in the last 2 years

Dacheng Xie

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6420-6620; OpenAlex author ID A5109602090. Sources: OpenAlex.

Their work

Papers
15 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
35
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 3 papers · 2015: 3 papers · 2016: none · 2017: 3 papers · 2018: none · 2019: 1 paper · 2020: 3 papers · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 15

  1. Innate immune cell barrier-related genes inform precision prognosis in pancreatic cancer. Co-author DOI 10.3389/fimmu.2025.1559373↗
  2. A novel KDM5A/MPC-1 signaling pathway promotes pancreatic cancer progression via redirecting mitochondrial pyruvate metabolism. Co-author DOI 10.1038/s41388-019-1051-8↗
  3. Methylation of HSP70 Orchestrates Its Binding to and Stabilization of BCL2 mRNA and Renders Pancreatic Cancer Cells Resistant to Therapeutics. Co-author DOI 10.1158/0008-5472.can-19-1738↗
  4. The FOXM1/ATX signaling contributes to pancreatic cancer development. Co-author PMID 32913521↗
  5. Pancreatic Acinar-to-Ductal Metaplasia and Pancreatic Cancer. First author DOI 10.1007/978-1-4939-8879-2_26↗
  6. STK33 Promotes Growth and Progression of Pancreatic Cancer as a Critical Downstream Mediator of HIF1α. Co-author DOI 10.1158/0008-5472.can-17-0067↗
  7. The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-16-1064↗
  8. DNA-Methyltransferase 1 Induces Dedifferentiation of Pancreatic Cancer Cells through Silencing of Krüppel-Like Factor 4 Expression. Co-author DOI 10.1158/1078-0432.ccr-17-0387↗
  9. Pancreatic cancer stromal biology and therapy. Co-author DOI 10.1016/j.gendis.2015.01.002↗
  10. Activation of vitamin D receptor signaling downregulates the expression of nuclear FOXM1 protein and suppresses pancreatic cancer cell stemness. Co-author DOI 10.1158/1078-0432.ccr-14-2437↗
  11. Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression. Co-author DOI 10.18632/oncotarget.5772↗
  12. Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells. Co-author DOI 10.1053/j.gastro.2014.04.048↗
  13. FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator sys… First author DOI 10.1158/1078-0432.ccr-13-2311↗
  14. FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression. Co-author DOI 10.1158/1078-0432.ccr-13-2407↗
  15. Sp/KLF family and tumor angiogenesis in pancreatic cancer. Co-author DOI 10.2174/13816128112092420↗

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Keping Xie · 12 shared papers, 2014–2025 · strength 1.09
  2. Daoyan Wei · 7 shared papers, 2014–2020 · strength 0.54
  3. Jiujie Cui · 8 shared papers, 2012–2020 · strength 0.46
  4. Ming Quan · 4 shared papers, 2015–2020 · strength 0.38
  5. Yong Gao · 6 shared papers, 2014–2020 · strength 0.38
  6. Qiang Yi Luo · 1 shared paper, 2025 · strength 0.33
  7. Xiaojia Li · 1 shared paper, 2025 · strength 0.33
  8. Liang Wang · 3 shared papers, 2015–2019 · strength 0.28
  9. Fanyang Kong · 2 shared papers, 2017–2020 · strength 0.18
  10. Li Li · 1 shared paper, 2020 · strength 0.15
  11. Yong Gao · 1 shared paper, 2020 · strength 0.15
  12. Jiawei Du · 2 shared papers, 2017 · strength 0.13
  13. Sushovan Guha · 1 shared paper, 2020 · strength 0.12
  14. Tiansuo Zhao · 1 shared paper, 2020 · strength 0.11
  15. Liang Wang · 1 shared paper, 2020 · strength 0.11
  16. Xiangyu Kong · 2 shared papers, 2014–2017 · strength 0.10
  17. Yiqi Du · 2 shared papers, 2014–2017 · strength 0.10
  18. Weihua Jiang · 2 shared papers, 2012–2014 · strength 0.08
  19. Qingyong Ma · 1 shared paper, 2017 · strength 0.07
  20. Kun Guo · 1 shared paper, 2017 · strength 0.07
  21. Zhiwei Li · 1 shared paper, 2017 · strength 0.06
  22. Yongmin Yan · 1 shared paper, 2017 · strength 0.06
  23. Victoria K. Xie · 1 shared paper, 2017 · strength 0.06
  24. Xiangsheng Zuo · 1 shared paper, 2017 · strength 0.06
  25. Zhao‐Shen Li · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.